Trump administration reclassifies medical marijuana

In a major policy reversal, the Trump administration has moved to downgrade the federal classification of medical marijuana, recognizing its potential therapeutic benefits.

The order, signed by the acting attorney general, removes state-licensed products from the highly restrictive Schedule I category.

While the move does not legalize recreational use federally, it allows cannabis businesses to claim standard tax deductions and facilitates expanded clinical trials.

Industry leaders have hailed the decision as a boon for the sector, though some conservative lawmakers have voiced opposition to the change.